The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: Re-optimization Based Online Adaptive Radiotherapy of Anal Cancer
Official Title: ROAR-A: Re-optimization Based Online Adaptive Radiotherapy of Anal Cancer
Study ID: NCT05438836
Brief Summary: A single-arm, prospective, Phase II, single-center clinical trial that will investigate if daily online adaptive radiotherapy for anal cancer will significantly reduce early treatment-related GI toxicity compared with the historically reported rate for non-adaptive intensity modulated radiation therapy (IMRT).
Detailed Description:
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Oncology dept, Herlev and Gentofte Hospital, Herlev, , Denmark
Name: Eva S Serup-Hansen, MD, PhD
Affiliation: Herlev og Gentofte Hospital
Role: PRINCIPAL_INVESTIGATOR